Jianan Bai

8PUBLICATIONS
19CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 20, 2026
Orlistat combined with everolimus suppresses pancreatic neuroendocrine tumor progression via inhibiting PI3K/AKT/mTOR signaling mediated by SLFN5.

|Apr 21, 2026
HMGCS1 as a potential mediator of resistance to EZH2 inhibition via ferroptosis mediated by PI3K/AKT/mTOR pathway in the pancreatic neuroendocrine neoplasms.

|Apr 04, 2024
Small Extracellular Vesicle piR-hsa-30937 Derived from Pancreatic Neuroendocrine Neoplasms Upregulates CD276 in Macrophages to Promote Immune Evasion.

Yuan Zhong, Ye Tian, Yan Wang

|Apr 05, 2022
Prognostic Evaluation of Patients with Rectal Neuroendocrine Neoplasms and Hepatic Metastases: A SEER Database Analysis.

Lijun Yan, Yanling Xu, Jialing Pan

|Feb 07, 2020
Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis.

Xiaolin Li, Na Yu, Jun Li

|Apr 26, 2019
DNA Methylation of miR-122 Aggravates Oxidative Stress in Colitis Targeting SELENBP1 Partially by p65NF-κB Signaling.

Jianan Bai, Junchi Yu, Jintian Wang

Pageof 2

Frequent Collaborators

3 joint publications

Qiyun Tang

2 joint publications

Lijun Yan

2 joint publications

Qin Long

2 joint publications

Qiyun Tang